Sterling Pharmaceutical Services Recalls Eye Drops Over Sterility Concerns

Sterling Pharmaceutical Services has initiated a recall of nearly 750,000 bottles of various eye care products, including drops and ointments, due to a lack of assurance of sterility. The FDA classified this as a Class II recall, indicating potential temporary or reversible adverse health consequences for users. This action aims to mitigate health risks associated with potentially contaminated eye products.